Background: Mivacurium's rapid onset and short duration of action in c
hildren suggests that intramuscular administration might treat laryngo
spasm and facilitate tracheal intubation without producing prolonged p
aralysis. Accordingly, the authors measured the neuromuscular effects
of intramuscular mivacurium in anesthetized infants and children. Meth
ods: Twenty unpremedicated infants and children (3 months to 5 yr of a
ge) were anesthetized with nitrous oxide and halothane and permitted t
o breathe spontaneously. When anesthetic conditions were stable, mivac
urium was injected into the quadriceps or deltoid muscle. Minute venti
lation and adductor pollicis twitch tension were measured. The initial
mivacurium dose was 250 mu g/kg and was increased (to a maximum of 80
0 mu g/kg, at which dose the trial was ended) or decreased according t
o the response of the previous patient, the goal being to bracket the
dose producing 80-90% twitch depression within 5 min of drug administr
ation. Results: No patient achieved >80% twitch depression within 5 mi
n of mivacurium administration, Peak twitch depression was 90 +/- 13%
(mean +/- SD) for infants and 88 +/- 15% for children at 15.0 +/- 4.6
min and 18.4 +/- 6.4 min, respectively. Ventilatory depression (a 50%
decrease in minute ventilation or a 10-mmHg increase in end-tidal carb
on dioxide tension) occurred at 9.0 +/- 4.4 min in nine infants and 13
.6 +/- 7.5 min in 10 children; ventilatory depression did not develop
in one infant given a dose of 350 mu g/kg. Time to peak twitch depress
ion or ventilatory depression was not faster with larger doses. Conclu
sions: Although ventilatory depression preceded twitch depression, bot
h occurred later with intramuscular mivacurium than would be expected
after intravenous mivacurium or intramuscular succinylcholine. The aut
hors speculate that the onset of intramuscular mivacurium is too slow
to treat laryngospasm or to facilitate routine tracheal intubation in
infants or children, despite administration of large doses.